U.S. markets open in 5 hours 56 minutes

BioHemp International, Inc. (BKIT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 9:59AM EDT

BioHemp International, Inc.

244, 5th Avenue
Suite A-154
New York, NY 10001
United States

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees1

Key Executives

NameTitlePayExercisedYear Born
Mr. Daniel BlumPres, CEO, Sec., Treasurer & DirectorN/AN/A1990
Mr. C. Parkinson Lloyd J.D.Legal CounselN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


BioHemp International, Inc. focuses on operating in the fast-growing consumer hemp and cannabidiol (CBD) market through a strategic rollup of CBD distributors. It focuses on the creation of distribution platform for CBD providers. The company was formerly known as Blake Insomnia Therapeutics, Inc. and changed its name to BioHemp International, Inc. in June 2019. BioHemp International, Inc. was founded in 2012 and is based in New York, New York.

Corporate Governance

BioHemp International, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.